Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Biological Chemistry
Gilead Sciences-owned Kite Pharma is investing in cell therapy manufacturing in Europe. Kite has leased a site in Hoofddorp, the Netherlands, that will allow it to make highly personalized treatments, including the CAR T-cell therapy axicabtagene ciloleucel, which is sold in the U.S. as Yescarta and is under European regulatory review. Kite recently added research and manufacturing capacity in the U.S. when it acquired a building in Santa Monica, Calif., from Astellas Pharma and leased a facility in Gaithersburg, Md.
This article has been sent to the following recipient: